dowdupont complet merger add valu
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research feb
estim feb
price data feb
rate updat feb
currenc amount express
valuat growth profit
methodolog valu compani
chemic dupont complet merger equal august
new compani name dowdupont plan split
three separ compani end compani
agricultur materi scienc specialti product
agricultur compani name corteva agrisci
materi scienc compani retain name
specialti product compani keep dupont name
dowdupont portfolio split basic specialti
product basic chemic plastic barrier entri low
profit determin scale integr product
technolog energi feedstock cost enorm
size decad experi compani rival
come scale integr technolog shale ga boom
lower natur ga price unit state
dowdupont north american oper benefit rel
competitor use higher-cost feed naphtha take
advantag lower ga cost plan increas north
american capac howev feedstock cost
fluctuat rapidli invest low-cost sourc
compani wrap billion joint ventur saudi
aramco one largest oil ga compani world
build integr chemic complex saudi arabia flexibl
crack capabl facil benefit
lowest-cost feedstock world
compani advanc materi busi come
dupont side produc noteworthi high-profit
product year compani invent product
lycra kevlar wide applic textil
safeti equip teflon use nonstick cookwar
tyvek broadli use construct materi also demonstr
dupont success product develop innov
compani solid record innov think
abl replac earn older product fall
favor leapfrog new technolog
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
analyst note model creat pro forma model interim use new
compani releas joint financi actual financi may differ
dowdupont diversifi global chemic materi compani
form merger chemic dupont portfolio
includ basic chemic agricultur automot electron
commun construct healthcar safeti protect
compani also sell genet modifi seed make one
promin global seed provid end dowdupont plan
split three separ compani -- one compani agricultur
materi scienc specialti product
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
valuat growth profit feb
fair valu estim per share base
discount cash flow model impli price-to-earnings
around time enterpris value/adjust ebitda
roughli time base estim
forecast low- mid-single-digit compound annual
organ sale growth next five year led gain
firm attract advanc materi electron
agricultur busi expect outpac
global growth expect agricultur segment
drive growth compani long run
introduc new product grab fair share
emerging-market growth particularli south america
think oper profit remain mid- high
announc merger-of-equ transact
chemic manag laid annual run-rat
cost-sav target billion around total
cost includ research develop long-term
run rate cost save billion corpor cost
save account key differ estim
manag dupont expect save
presum includ typic back-offic cost
come oper public compani make sens
cost would decreas number compani
shrink two one one compani
long-term plan deal three compani think
corpor cost dissynergi long run
categori call
weight averag cost capit dowdupont
uncertainti rate dowdupont high
profit compani high-fixed-cost chemic
busi greatli affect plant oper rate lead
larg swing profit furthermor compani
expos up down oil natur ga
market fair valu estim also depend
compani abil continu develop
product dispar busi line
uncertain construct three scenario -- base
case describ valuat section bull case
bear case -- highlight rang potenti outcom
bull case assum strong stabl global
econom recoveri support demand oper rate
price power chemic industri scenario
also assum dowdupont success introduc
innov high-margin product electron
materi segment dupont advanc materi
segment carri mantl kevlar tyvek
other furthermor assum agricultur
busi abl close technolog gap biggest
rival monsanto win market share scenario also
assum rapid seed technolog adopt emerg
market bull-cas fair valu estim per share
bear case assum protract slowdown
global econom recoveri glut chemic capac
project greenlight result low north american
natur ga price bear case slower growth
oversuppli weigh chemic margin also assum
share loss agricultur pipelin product delay
fail match favor competitor offer
scenario dowdupont may forc cut price
stem share loss also assum lack new product
electron materi busi bear case
fair valu estim per share
base compani portfolio specialti busi
think agricultur busi biggest contributor
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
kevlar proprietari product becom materi
choic militari law enforc safeti
protect think intang asset held product
like contribut dowdupont narrow econom
compani health nutrit busi benefit
switch cost result acquisit fmc
health nutrit busi novemb
nutrit bioscienc segment hous health
nutrit busi key product includ microcrystallin
cellulos mcc use bind dri tablet
roughli half prescript written year
market function nonact ingredi
control releas polym although
signific drug patent expir come year
expect busi continu hold high market
share due high switch cost pharmaceut
product shift patent gener drug produc look
minim risk simplifi regulatori process use
ingredi chang drug includ
binder ingredi control releas
polym must demonstr equival origin
product difficult feat consid high standard
qualiti consist requir food drug
administr failur demonstr equival would
mean gener product pass regulatori
approv gener drug produc tend stick
binder function nonact ingredi
alreadi use patent product
dowdupont basic chemic busi oper cost
advantag major ethylen propylen
product use low-cost feedstock primarili natur ga
unit state compar higher-cost produc
use oil feedstock secur low-cost posit
dowdupont dual-prong approach compani
secur low-cost feedstock partnership
compani cost-advantag region
dowdupont moat merger dupont
agricultur busi second wide-moat monsanto
biotech seed built solid posit market
control strong germplasm seed bank capabl
distribut market oper dupont even
best monsanto recent year market front
region strategi
set compani long-term success gm seed
adopt emerg market exampl enlist corn
seed first gm corn approv import
china think first step toward eventu gm
adopt although dowdupont yet
monsanto technolog front maintain portfolio
patent trait difficult replic
help maintain posit formid competitor
besid agricultur compani success develop
innov materi creat group patent
product enjoy premium posit market
exampl dupont advanc materi busi
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
upcom sadara project saudi arabia invest
 expans exploit low natur ga price
think firm specialti chemic portfolio
demand elev margin enjoy higher barrier
entri stickier custom relationship enough
overcom risk associ basic chemic
industri econom cycl expect dowdupont
gener return invest capit cost
moat trend dowdupont stabl compani
posit agricultur market genet modifi
seed crop chemic continu gener
attract return likewis record develop
innov higher-margin product materi
dupont advanc materi electron
busi allow compani continu develop
new product old one fall favor
also think compani basic chemic product
retain cost advantag produc
access low-cost natur ga said
commodit chemic busi compani
 gulf coast asset enjoy low-cost natur ga
moment energi market dynam
dowdupont control ultim determin
profit firm basic chemic asset
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
odowdupont benefit greater feedstock flexibl
averag basic chemic produc north
america europ give opportun ad
profit period fluctuat input output
odowdupont invest feedstock
gulf coast middl east boost
profit downstream busi
oth chemic dupont merger creat
valu sharehold
oa plethora announc petrochem project
 could eventu lead oversuppli
oth dupont agricultur busi continu reli
rival monsanto soybean technolog
strain integr enlist technolog
seen dowdupont oper cyclic
industri get pound downturn
global economi recent slowdown growth
bode well near-term prospect
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
dowdupont approxim billion debt
billion cash dec net debt/ebitda
manag time end
expect ratio remain healthi
dowdupont face stiff competit across chemic
seed market major petrochem produc
expos up down oil natur ga
market typic hydrocarbon feedstock energi
account compani product cost
oper expens firm also oper mani
highli cyclic end market includ construct
automot furthermor chemic industri cyclic
right make capac addit result
oversuppli threat addit guarante
invest research develop next
gener biotech trait bear fruit compani
could fall behind monsanto risk agricultur
includ possibl weed bug could develop
resist firm product render dowdupont
turn bioengin crop unit state
south america similar condit europ failur
develop new product could also hit firm specialti
busi two third sale outsid
 compani expos fluctuat foreign
currenc like chemic produc compani
continu face possibl environment
health-rel remedi cost asbesto
liabil dupont recent settl pofa toxic chemic
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
repres date owner name posit common share held report holder issuer
va collegeamerica incom fund america
fidel manag research compani
share
fund
share
fund
edward breen held titl dupont
merger sinc octob previous ceo
tyco bring compani
back brink bankruptci andrew liveri
execut chairman liveri began career
chemic ceo
merger dupont close
merger dupont manag
team histori decent capit alloc dow focu
develop specialti chemic portfolio
expans low-cost feedstock like creat
sharehold valu likewis dupont divestitur
gear portfolio toward specialti chemic
also like invest predecessor compani
develop genet modifi seed
think potenti creat avenu growth
next coupl decad
think recent close merger creat valu
sharehold manag cost synergi revenu
synergi estim seem overli aggress said
primarili base stewardship
rate actual
capital-alloc decis area think
compani manag done decent job
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
rais dowdupont fair valu estim
dowdupont report solid fourth-quart earn
compani first full quarter merger oper
ebitda grew year year billion pro forma
basi profit boost oper leverag
higher volum across segment increas
fair valu estim per share due
expect slightli higher cost-sav synergi
result merger narrow moat rate unchang
dowdupont earn releas manag
increas annual cost save synergi forecast
billion billion bulk cost save increas
stem decreas use contract manufactur
product agricultur health nutrit
busi merger dupont use
third-parti manufactur small portion product
compani util previous unus capac
across combin busi significantli lower
product cost result weve increas estim
compani annual cost-sav synergi
billion billion howev still see area
leverag servic becom dissynergi dowdupont
split three compani
still think spin-off complet end
exampl dissynergi begin occur
prepar separ dowdupont
design implement separ system three
compani three system like carri higher
oper cost use singl system spin-off
occur
dowdupont report decent result first quarter
report one compani merger close
end august oper ebitda year-on-
year pro forma basi thank volum growth
specialti chemic busi materi scienc
busi addit earn announc
compani announc complet two three
requir divestitur relat regulatori approv
merger includ transact close
nov chang outlook dowdupont
maintain per share fair valu estim narrow-
moat rate also unchang
transact dowdupont sold certain
dupont crop chemic asset exchang health
nutrit busi billion
cash
approxim million work capit think
health nutrit busi benefit switch cost
relat avicel market lead dri tablet
binder pharmaceut industri even drug
come patent gener manufactur like stick
avicel easili gain regulatori approv
gener drug health nutrit busi becom
part nutrit bioscienc segment
earlier quarter manag final plan
break dowdupont three separ compani
agricultur compani specialti product compani
spin-off complet end
break-up occur dowdupont begin implement
manag plan captur billion annual cost
save synergi billion annual growth synergi
continu forecast billion annual synergi
forecast billion dis-synergi come
run three compani instead one
inform outlook spin-off plan
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
see sept note dowdupont announc final
spin-off maintain fve
dowdupont announc final spin-off plan
review consult firm mckinsey plan remain
split three compani within next month
howev busi previous slate
becom part materi scienc compani move
specialti product compani maintain
fair valu estim narrow moat rate
dowdupont still intend split agricultur specialti
product materi scienc compani specialti
product compani pro forma revenu around
billion compris four divis similar revenu
electron imag transport advanc
polym safeti construct nutrit
bioscienc given four segment distinct
busi oper separ would
surpris specialti product compani split four
separ compani point note
four busi gener similar revenu
previou divestitur axalta
continu expect billion annual cost-sav
dowdupont achiev major cost-sav
measur pertain cost good sold sell gener
administr expens research develop
save would produc around
billion annual cost synergi howev continu
forecast billion annual dissynergi creat
extra expens associ oper three busi
instead two specialti product spin-off split
multipl compani would probabl increas
materi scienc compani continu largest
three around billion pro forma
revenu busi almost exclus produc basic
commod chemic product benefit
agricultur compani billion pro forma
revenu combin dupont agricultur
segment remain skeptic synergi
two agricultur busi dupont
agreement monsanto use genet modifi
technolog featur annual minimum payment
billion make switch dow gm technolog
prohibit expens agreement run
valu dowdupont per share merger
merger chemic dupont close
end august combin entiti trade
dowdupont dwdp ticker assign dowdupont
per share fair valu estim narrow econom
moat rate base intang asset firm
portfolio patent product well cost advantag
basic chemic product fair valu estim
current trade price
base view compani abl
achiev manag estim billion annual cost-
save synergi instead forecast achiev
synergi billion although synergi target
typic reason two compani merg
one long-term goal split three
compani ultim drive dis-synergi
extra expens longer time horizon
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
incom equiti invest
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
